280 results
8-K
LFCR
Lifecore Biomedical Inc
7 Jun 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
beliefs, assumptions and expectations regarding future events, which in turn are based on information currently available to the Company. By their nature
8-K
LFCR
Lifecore Biomedical Inc
16 May 24
Lifecore Biomedical Completes Incremental Liquidity Initiatives
4:48pm
to the Company. By their nature, forward-looking statements address matters that are subject to risks and uncertainties. A variety of factors could cause
8-K
EX-10.1
LFCR
Lifecore Biomedical Inc
14 May 24
Entry into a Material Definitive Agreement
5:04pm
offset, defense or counterclaim of any kind, nature or description whatsoever. (b) Acknowledgement of Loan Documents. The Loan Parties hereby acknowledge … , disputes, causes, damages, actions and causes of actions (whether at law or in equity) and obligations of every nature whatsoever, whether liquidated
8-K
LFCR
Lifecore Biomedical Inc
14 May 24
Entry into a Material Definitive Agreement
5:04pm
on information currently available to the Company. By their nature, forward-looking statements address matters that are subject to risks
8-K
LFCR
Lifecore Biomedical Inc
19 Apr 24
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
4:34pm
and expectations regarding future events, which in turn are based on information currently available to the Company. By their nature, forward-looking statements
8-K
EX-10.3
v5yp fyxymfghf
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
8-K
EX-10.2
42jogfhx
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
8-K
78x vgs0w62r
12 Jan 24
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
4:51pm
8-K
EX-10.2
y5jlj l9c
5 Jan 24
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-10.3
0rkw05s3gqrp 5v
5 Jan 24
Entry into a Material Definitive Agreement
4:09pm
8-K
ufc3v2eptle95hhuc
31 Oct 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
6:17am
8-K
at19q53
18 Oct 23
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
4:07pm
8-K
lc8g7txpnz 381r5s
22 Aug 23
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
4:11pm
8-K
EX-10.1
4pq5jedywtjfh evnjbk
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
1dc6r8d4 jlwl
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm